Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics, Inc. (UNCY) is a healthcare company (biotechnology) based in the United States. The share price is $3.70, up 0.00% on the day, which values the company at $107.98M. Price as of 18 Nov 2026, 11:43 UTC, from Yahoo Finance.

Key facts

Share price
$3.70+0.00% today
Market value
$107.98M
Forward P/E
5.4×
200-week average
$7.4951% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Unicycive Therapeutics, Inc. in more detail

UNCY trades at 5.4× next year's expected earnings. It sits 51% below its 200-week average of $7.49.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Unicycive Therapeutics, Inc. (UNCY): questions and answers

What is Unicycive Therapeutics, Inc.'s market cap?

Unicycive Therapeutics, Inc. is valued at $107.98M at a share price of $3.70.

Is UNCY above its 200-week moving average?

No. UNCY is 50.6% below its 200-week average of $7.49. Long-term investors watch that line because strong companies rarely trade below it for long.

Does UNCY pay a dividend?

Unicycive Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Unicycive Therapeutics, Inc. (UNCY) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/UNCY

Underlying data: Yahoo Finance; company filings with the SEC.